Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2024 Financial Results on February 10, 2025
Inspire Medical Systems (NYSE: INSP) has announced it will release its fourth quarter and fiscal 2024 financial results after market close on Monday, February 10, 2025. The company's management will host a conference call at 5:00 p.m. Eastern Time to discuss financial results and recent business developments.
The earnings call will be accessible through two options: a webcast via the company's Investor Relations page for those planning to listen only, and a separate registration link for participants who wish to ask questions. Participants planning to ask questions are advised to register at least 10 minutes before the call. A replay will be available on the Investor Relations website approximately two hours after the event and will remain archived for two weeks.
Inspire Medical Systems (NYSE: INSP) ha annunciato che presenterà i suoi risultati finanziari del quarto trimestre e dell'anno fiscale 2024 dopo la chiusura del mercato, lunedì 10 febbraio 2025. La direzione dell'azienda ospiterà una call di conferenza alle 17:00 ora orientale per discutere i risultati finanziari e gli sviluppi recenti dell'attività.
La call sugli utili sarà accessibile attraverso due opzioni: una diretta web tramite la pagina delle Relazioni con gli Investitori dell'azienda per coloro che intendono ascoltare solo, e un link di registrazione separato per i partecipanti che desiderano porre domande. I partecipanti che intendono fare domande sono invitati a registrarsi almeno 10 minuti prima della call. Una registrazione sarà disponibile sul sito delle Relazioni con gli Investitori circa due ore dopo l'evento e rimarrà archiviata per due settimane.
Inspire Medical Systems (NYSE: INSP) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año fiscal 2024 después del cierre del mercado el lunes 10 de febrero de 2025. La dirección de la empresa organizará una llamada de conferencia a las 5:00 p.m. hora del Este para discutir los resultados financieros y los recientes desarrollos comerciales.
La llamada de ganancias será accesible a través de dos opciones: una transmisión web a través de la página de Relaciones con Inversores de la empresa para aquellos que planean escucharlo solo, y un enlace de registro separado para los participantes que deseen hacer preguntas. Se aconseja a los participantes que planean hacer preguntas que se registren al menos 10 minutos antes de la llamada. Una repetición estará disponible en el sitio web de Relaciones con Inversores aproximadamente dos horas después del evento y permanecerá archivada durante dos semanas.
Inspire Medical Systems (NYSE: INSP)는 2024 회계연도 4분기 재무 결과를 2025년 2월 10일 월요일 시장 폐장 후 발표할 것이라고 발표했습니다. 회사 경영진은 동부 표준시 기준으로 오후 5시에 재무 결과 및 최근 사업 개발에 대해 논의하기 위한 컨퍼런스 콜을 주최할 예정입니다.
실적 발표 콜은 두 가지 옵션을 통해 접근할 수 있습니다: 개인적으로 듣기만 원하는 사람들을 위한 회사의 투자자 관계 페이지를 통한 웹캐스트와 질문을 하고 싶은 참가자를 위한 별도의 등록 링크입니다. 질문을 할 계획인 참가자는 콜 시작 10분 전까지 등록할 것을 권장합니다. 이벤트 후 약 2시간 이내에 투자자 관계 웹사이트에서 재청취가 가능하며 2주 동안 아카이브됩니다.
Inspire Medical Systems (NYSE: INSP) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'exercice 2024 après la clôture des marchés le lundi 10 février 2025. La direction de l'entreprise animera une conférence téléphonique à 17h00, heure de l'Est, pour discuter des résultats financiers et des développements récents.
La conférence sur les résultats sera accessible via deux options : un webinaire via la page des Relations Investisseurs de l'entreprise pour ceux qui prévoient seulement d'écouter, et un lien d'inscription séparé pour les participants souhaitant poser des questions. Il est conseillé aux participants prévoyant de poser des questions de s'inscrire au moins 10 minutes avant l'appel. Une rediffusion sera disponible sur le site des Relations Investisseurs environ deux heures après l'événement et sera archivée pendant deux semaines.
Inspire Medical Systems (NYSE: INSP) hat angekündigt, dass es seine Finanzergebnisse für das vierte Quartal und das Geschäftsjahr 2024 nach Börsenschluss am Montag, den 10. Februar 2025, veröffentlichen wird. Das Management des Unternehmens wird um 17:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Finanzergebnisse und aktuelle Geschäftsentwicklungen zu besprechen.
Der Gewinnaufruf wird über zwei Optionen zugänglich sein: einen Webcast über die Investor-Relations-Seite des Unternehmens für diejenigen, die nur zuhören möchten, und einen separaten Registrierungslink für Teilnehmer, die Fragen stellen möchten. Teilnehmer, die Fragen stellen möchten, wird geraten, sich mindestens 10 Minuten vor dem Anruf zu registrieren. Eine Wiederholung wird etwa zwei Stunden nach der Veranstaltung auf der Investor-Relations-Website verfügbar sein und für zwei Wochen archiviert bleiben.
- None.
- None.
MINNEAPOLIS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and fiscal 2024 after the close of trading on Monday, February 10. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q4 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.
If you plan to ask a question, please use the following link: Inspire's Q4 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.
Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
When will Inspire Medical Systems (INSP) report Q4 2024 earnings?
What time is Inspire Medical Systems' (INSP) Q4 2024 earnings call?
How can investors access Inspire Medical Systems' (INSP) Q4 2024 earnings call?
How long will Inspire Medical Systems' (INSP) Q4 2024 earnings call replay be available?
